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SUMMARY  ·  The aim of the study was to determine the possible association between the dura-
tion of diabetes mellitus and prevalence of ischemic stroke. Also, the effect of hyperglycemia in the
acute phase of ischemic stroke on short-term outcome of stroke was studied. Study group consisted
of 429 patients hospitalized at our department for ischemic stroke during 12 consecutive months.
The diagnosis and type of diabetes were established on the basis of pre-stroke history data and con-
firmed by consultant diabetologist (glucose monitoring by repeated blood tests). The diagnosis and
outcome of brain infarction were assessed on the basis of clinical and neuroimaging criteria. Hyper-
glycemia was recorded in 95 patients with ischemic stroke (22.1% of all cases); 72 of them had the
diagnosis of diabetes mellitus established prior to stroke (type 1 in nine, and type 2 in 63 patients).
There were 63 females and 42 males, mean age 68.6±7.8 years. Hypertension was an additional risk
factor for stroke in 87.4%, while elevated blood cholesterol was found in only 31.1% of patients.
Brain imaging showed territorial infarction in 46 cases of ischemic stroke, followed by 21 cases of
lacunar infarction, and hemodynamic stroke in two cases. Diabetes of ≥6 years of duration was asso-
ciated with a higher rate of ischemic stroke than the shorter diabetes duration of up to 5 years (50 vs
22 patients). Further analysis revealed a significant difference in stroke prevalence between the pa-
tients with type 2 diabetes duration of 6-10 and ≥11 years (p<0.01); in the group of patients with
longest diabetes duration, the presence of this disease facilitated the occurrence of stroke. The func-
tional outcome of stroke as assessed by the Modified Rankin Scale showed a more severe functional
deficit in the group of patients with hyperglycemia (Rankin 0 and 1 in 7.4%, Rankin 2 and 3 in
28.7%, and Rankin 4 and 5 in 35.2% of all cases) than in the group of ischemic stroke patients with-
out hyperglycemia (Rankin 0 and 1 in 24.2%, Rankin 2 and 3 in 27.4%, and Rankin 4 and 5 in 26.2%
of all cases). The case fatality rate was higher in the former than in the latter group of patients (28.7%
vs 22.2% of all cases). Diabetes was found to be an important risk factor for ischemic stroke. Pro-
longed duration of diabetes had greater impact on the occurrence of stroke than shorter duration of
the disease. The presence of hyperglycemia in the acute phase of stroke aggravates the final outcome
of ischemic stroke. Thus, early detection and management of hyperglycemia should be considered
important measures for the prevention of stroke.
Key words: Brain ischemia, complications; Hyperglycemia; Diabetes mellitus, complications; Diabetes mel-
litus, epidemiology
may be increased through multiple and synergistic mecha-
nisms such as acceleration of large artery sclerosis, adverse
effects on high density lipoprotein (HDL) cholesterol lev-
els, increased level of thrombohexane, and hyperin-
sulinemia5. However, tight control of blood glucose lev-
els does not reduce significantly the risk of macrovascular
complications in diabetics, as it does in case of microvas-
cular complications of diabetes mellitus6. Furthermore,
there is a dispute whether hyperglycemia in the acute
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Introduction
Large population-based epidemiological studies have
demonstrated that diabetes mellitus is a major risk factor
for ischemic stroke1-4. The risk of thromboembolic stroke
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phase of stroke is associated with poor stroke prognosis7.
It has been suggested that the duration of hyperglycemia
preceding cerebral ischemia may also be a contributory
factor for the occurrence of stroke, although the mecha-
nism of this effect remains uncertain8.
In this study, an attempt was made to determine the
possible association between the duration of diabetes
mellitus and prevalence of ischemic stroke. Also, the ef-
fect of hyperglycemia on the short-term outcome of the
acute phase of ischemic stroke was assessed.
Patients and Methods
Data were collected from ischemic stroke patients ad-
mitted to the Department of Neurology, Osijek University
Hospital, Osijek, Croatia, during 12 consecutive months.
Basic patient characteristics are shown in Table 1. The di-
agnosis and type of diabetes mellitus (insulin dependent
(IDDM) or non-insulin dependent (NIDDM) diabetes
mellitus) were established on the basis of pre-stroke history
data and confirmed by a consultant diabetologist. Glucose
levels were monitored by repeated blood tests. Blood
samples for serum glucose determination were obtained
immediately upon admission, and then daily throughout
their hospital stay. Non-diabetic patients were considered
to have hyperglycemia if their fasting glucose levels ex-
ceeded 6.4 mmol/L on admission and spontaneously nor-
malized during the first week of hospitalization.
The diagnosis of brain infarction was made on the
basis of clinical and neuroimaging criteria. Computed
tomography (CT) images were used to define stroke sub-
type: lacunar infarction, territorial infarction, hemody-
namic infarction, or undefined infarction. The outcome of
stroke was assessed 30 days upon admission using the
Modified Rankin Scale.
Results
In the present study, 95 (22.1%) patients had elevated
fasting blood glucose level in the acute phase of ischemic
stroke. Seventy-two (16.8% of all ischemic stroke patients)
patients had a history of diabetes (nine IDDM and 63
NIDDM) prior to stroke. Patients with glucose intoler-
ance were on an average older than those with ischemic
stroke. The former group was characterized by female
predominance, while an equal sex distribution was ob-
served in the latter (Table 1). Hypertension was found to
be an additional risk factor for ischemic stroke in 87.4%
of patients with hyperglycemia, while elevated blood cho-
lesterol was recorded in only 31.1% of them.
Table 1. Basic patient characteristics
Characteristic Ischemic stroke patients
With glucose intolerance Total
No. of patients 95 429
Mean age (yrs) 68.6±7.8 63.6±12.3
Sex (M/F) 42/53 220/209
Brain imaging analysis showed territorial infarction in
46 cases of ischemic stroke and hyperglycemia, followed
by 21 cases of lacunar infarction, while two stroke cases
were found to have a hemodynamic pathophysiology. In
26 cases, the localization or pathophysiology of stroke
could not be determined by CT brain scan. There was no
clinical or CT evidence of hemorrhage in the infarction
area.
Diabetic patients were classified into three groups ac-
cording to their history data: diabetes duration of ≤5, 6-
10 or ≥11 years. The prevalence of ischemic stroke and its
association with the duration of either IDDM or NIDDM
are presented in Fig. 1. Diabetes duration of ≥6 years was
associated with more ischemic stroke cases than shorter
diabetes duration of ≤5 years. Further analysis yielded a
significant difference in stroke prevalence between pa-
tients with NIDDM duration of 6-10 years and ≥11 years
(p<0.01). In the group of patients with the longest dura-
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tion of diabetes mellitus, most of stroke cases were found
to have been facilitated by the presence of diabetes.
The functional outcome of stroke as assessed by the
Modified Rankin Scale showed a more severe functional
deficit in the group of patients with hyperglycemia in com-
parison to the group of ischemic stroke patients without
hyperglycemia. The case fatality rate was higher in the
former than in the latter group (28.7% vs 22.2% of all
cases) (Fig. 2).
hyperglycemia. One can only speculate that some of the
patients who had hyperglycemia and no history of diabe-
tes may have had a previously unrecognized (latent) form
of diabetes.
Using CT images, we demonstrated that most of the
infarctions associated with hyperglycemia occurred in the
territory of large cerebral vessels, and they were likely
caused by a thrombotic and/or embolic event following
atherosclerotic plaque transformation. Some evidence in-
dicate that hyperglycemia intensifies brain injury second-
ary to cerebral ischemia in animals. On the other hand,
large strokes may lead to stress hyperglycemia and to
poorer prognosis12. No hemorrhagic transformation of the
infarction with acute hyperglycemia was detected on CT
scans, as it has previously been reported13.
We found that longer duration of diabetes significantly
contributed to the occurrence of ischemic stroke. This as-
sociation seems not to be as linear as suggested by two pre-
viously published multivariate analyses of the main risk
factors for stroke in middle-aged and elderly population
of Finland8,14. There was a fall in the risk of ischemic
stroke for patients with NIDDM duration of 6-10 years,
so it may seem that in this period diabetes is not as criti-
cal for brain ischemia. However, history data for NIDDM
are not reliable enough to determine the onset of
NIDDM, because there is strong evidence that its onset
may actually occur many years before the clinical diagno-
sis15.
Acute hyperglycemia influenced the outcome of is-
chemic stroke at 30 days from its onset. The neurologic
deficit in our patients with hyperglycemia was more se-
vere than in those without hyperglycemia. Consequently,
the case fatality rate was higher in the former group. Our
data are comparable with the results of Toni et al.7, al-
though they speculate that moderate hyperglycemia in
some of their non-diabetic patients (those with suppos-
edly slight reduction of blood flow in the brain infarction
area) may have even had some beneficial effect. On the
other hand, van Knooten et al.16 report that ‘stress’ hyper-
glycemia in acute stroke had no impact on stroke severity
at early onset, but significantly correlated with stroke out-
come. In fact, many of these patients may have a latent
form of diabetes mellitus17.
In conclusion, diabetes mellitus is an important risk
factor for ischemic stroke. Prolonged diabetes duration has
a greater contributory effect on the occurrence of stroke
than shorter duration of the disease. The presence of hy-
perglycemia in the acute phase of stroke aggravates the
final outcome of ischemic stroke. Thus, early detection and





























Results of our study conducted in the population of the
Osijek area confirmed diabetes mellitus as a major risk fac-
tor for ischemic stroke, accounting for 17% of all ischemic
stroke patients, i.e. a proportion similar to those reported
from large population-based studies in developed coun-
tries2,4,9. In our diabetic patients, ischemic stroke was
found to be associated with age, female gender, hyperten-
sion, and to a lesser extent with blood cholesterol. Our
findings are consistent with the results of a multivariate
regression analysis study of risk factors for atherothrom-
botic brain infarction, showing that glucose intolerance is
an independent contributor to stroke only in women aged
over 65, and of another study on stroke in type 2 diabetes
patients showing that hypertension has to be regarded as
the best predictor of stroke outcome10,11.
NIDDM was the most common cause of hyperglyce-
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management of hyperglycemia should be considered im-
portant measures in the prevention of stroke.
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Saæetak
HIPERGLIKEMIJA U BOLESNIKA S ISHEMIJSKIM MO}DANIM UDAROM
D. JanËuljak, J. PaliÊ, D. Vuka¹inoviÊ, B. Barac, I. Bradvica, B. RadanoviÊ, D. KadojiÊ i R. PaliÊ
Cilj ovoga istraæivanja bio je utvrditi moguÊu povezanost duljine trajanja dijabetesa i pojave ishemijskog moædanog udara
(IMU). Usto, ispitan je i uËinak hiperglikemije u akutnoj fazi IMU na ishod nakon 30 dana lijeËenja. U ispitivanju je bilo
obuhvaÊeno 429 hospitaliziranih bolesnika koji su lijeËeni tijekom 12 uzastopnih mjeseci zbog IMU na na¹oj klinici. Dijagnoza
dijabetesa i njegove podvrste postavljena je na osnovi povijesti, a potvrðena konzilijarnim pregledom dijabetologa. Glikemija
je praÊena ponovljenim serumskim pretragama. Dijagnoza i ishod IMU procijenjeni su prema kliniËkim i neuroradiolo¹kim
kriterijima. Hipeglikemija je ustanovljena u 95 bolesnika s IMU (u 22,1% svih sluËajeva IMU); od toga je 72 bolesnika imalo
dijagnozu dijabetesa prije moædanog udara (devetoro tipa 1, a 63 tipa 2). ProsjeËna dob bila je 68,6±7,8 godina, 53 æene i 42
mu¹karca. Hipertenzija je bila dodatni Ëimbenik rizika u 87,4%, dok je povi¹eni kolesterol naðen u samo 31,1% bolesnika.
Neuroradiolo¹ki je teritorijalni infarkt dokazan u 46, a lakunarni infarkt u 21 bolesnika s IMU, dok je samo dvoje bolesnika
imalo hemodinamski infarkt. Trajanje dijabetesa od vi¹e od 6 godina bilo je znaËajno povezano s veÊim brojem IMU nego kraÊe
trajanje dijabetesa do 5 godina (50 prema 22 bolesnika). Daljnja analiza pokazala je statistiËki znaËajnu razliku u broju IMU
izmeðu skupine s trajanjem dijabetesa tipa 2 od 6-10 godina i one s 11 i vi¹e godina (p<0,01), gdje je veÊi broj bolesnika s
IMU zabiljeæen u skupini s najduæim trajanjem dijabetesa. Funkcionalni ishod IMU procijenjen je modificiranom Rankinovom
ljestvicom. U skupini bolesnika s hiperglikemijom neurolo¹ki deficit bio je teæega stupnja (Rankin 0 i 1 u 7,4%, Rankin 2 i
3 u 28,7% te Rankin 4 i 5 u 35,2% bolesnika) u usporedbi s bolesnicima bez hiperglikemije (Rankin 0 i 1 u 24,2%, Rankin
2 i 3 u 27,4% te Rankin 4 i 5 u 26,2% bolesnika). Stopa smrtnosti nakon 30 dana bila je vi¹a u prvoj nego u potonjoj skupini
bolesnika (28,7% prema 22,2%). Dijabetes je vaæan Ëimbenik rizika za IMU u promatranoj populaciji. Duæe trajanje dijabetesa
znaËajnoj vi¹e doprinosi pojavi IMU nego kraÊe trajanje bolesti. Prisutnost hiperglikemije u akutnoj fazi moædanog udara
pogor¹ava kratkoroËni ishod IMU. Zato je rano otkrivanje i lijeËenje hiperglikemije vaæan Ëimbenik u prevenciji moædanog
udara.
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